This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Sigma-Aldrich Corporation - Special Call

We have over 9,000 employees and we are in many, many countries. We have operations in many countries where we do business. Practically everywhere in the world, our customers expect us to provide similar service levels. And I'll tell you, our service levels in the emerging market have been growing up quite significantly which has also led to a very rapid growth for Sigma-Aldrich. I'll let the team, when they come, and talk about what we've been able to achieve in the last year or 2.

Two distinct businesses, most of you know that. We enable science for both manufacturing, as well as enable science in the lab. Our Research business, or the business that we have that caters to researchers, is about a little over 70% of our business. And then close to 30% of our business is in what we refer to as the SAFC, or the Fine Chemical business. And I will give you a little introduction on both and then of course Frank Wicks, who runs our Global Research business is going to be down here speaking about that business, and Gilles Cottier, who runs our SAFC business will do the same for SAFC.

The Research business really, if you look at the strategy of what we are trying to do there, we are selling convenience, we are selling science, we are selling products. But it's the convenience that provides a very broad portfolio of products to our customers who trust the quality in the service that we provide. And frankly, the franchise is strong because of all the things that we offer. Now if you've seen the layers within the Research business of what we do, you can see there are several things that we do. Our Biology business is almost 1/2 of what we do in research today. So biology based products, about 1/2. And then in biology, we have the traditional Biology business, which is selling BioBasics, which we have done as a company since it began. It's a very solid business, a very profitable business for us. And then as you know for the last several years, we have been getting into the more innovative areas of biology. And Frank and David Smoller will be here to talk about that, but we're into biomolecules, we're into Functional Genomics, we're into all sorts of series of [ph] cells. And we are into things like gene editing. Businesses within that innovative Biology business that are growing very, very rapidly for us. I mean, we'll point that out to you.

5 of 9

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs